ENGN
enGene Holdings Inc

1,174
Mkt Cap
$677.26M
Volume
94,138.00
52W High
$12.25
52W Low
$2.65
PE Ratio
-4.41
ENGN Fundamentals
Price
$10.00
Prev Close
$10.11
Open
$9.72
50D MA
$9.48
Beta
0.43
Avg. Volume
431,987.95
EPS (Annual)
-$2.29
P/B
3.14
Rev/Employee
$0.00
$206.55
Loading...
Loading...

About

enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
82

Frequently Asked Questions

What is Market Cap of enGene Holdings Inc?
What is the 52-week high for enGene Holdings Inc?
What is the 52-week low for enGene Holdings Inc?
What is enGene Holdings Inc stock price today?
What was enGene Holdings Inc stock price yesterday?
What is the PE ratio of enGene Holdings Inc?
What is the Price-to-Book ratio of enGene Holdings Inc?
What is the 50-day moving average of enGene Holdings Inc?
How many employees does enGene Holdings Inc have?

Latest ENGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.